483 WES Pharma Feb 2022

483 WES Pharma Feb 2022

Mindy Chou FDA, Natasha Gupta FDA$119.00 - Available Now

FDA investigators audited the WES Pharma - Westminster, MD, United States facility and issued inspectional observations (via FDA 483) on 18 Feb 2022.

Product details

  • Category: Human Drugs
  • Inspection end: 18 Feb 2022
  • Location: Westminster, United States
  • FEI: 3010062344
Add To Cart